Calley Means joins Dasha Burns at a Politico health care summit to discuss HHS Secretary Robert F. Kennedy Jr.'s MAHA agenda.

A group of Canadian undergrads is using plants to revolutionize medicine. Faced with soaring drug prices and global shortages ...

How the culture distinguishes health care choices between natural based medicinal options and evidence-based ...

A new study found that spending on GLP-1 medications such as Ozempic, Wegovy and Zepbound surged to $5.8 billion in 2022 among U.S. adults without diabetes. The research, published April 1 in the ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

Meghan Trainor also said she is 'trying to biohack' her body when asked about her drastic weight loss at the 2025 Billboard ...

The attorneys general sent a letter saying the FDA needs to take action because high demand for the weight loss drugs paired ...

Whether you’re on a weight loss journey of your own or not, you probably haven’t been able to avoid hearing about the sudden ...

Starting next month, the Food and Drug Administration will restrict who can make and sell popular weight-loss medications known as  GLP-1s.

A Medicine study used artificial intelligence to discover a naturally occurring molecule, specifically, a peptide, that ...

Ozempic is already approved to treat chronic kidney disease ... and reap cardiovascular health benefits from it," said Dr.

As a diabetes medication, GLP-1s are able to treat insulin resistance, something that many people with PCOS deal with. “It’s ...